<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160110025937N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-11-03</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of The effect of early mobilization protocol at three and four phase on clinical outcome in patients undergoing coronary artery bypass graft:a single blinded randomized clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of The effect of early mobilization protocol at three and four phase on clinical outcome in patients undergoing coronary artery bypass graft:a single blinded randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-10-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40561</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: Random allocation is done using computer random numbers table, Randomization description: The present study is a single-blind randomized clinical trial with a three-arm parallel design. After obtaining the permission of the Ethics Committee and the registration of the study at the Iranian Center for Clinical Trials, available randomly selected samples will be randomly assigned with a 1: 1: 1 ratio in the control group and the first intervention group and the intervention group. Random assignment sequence by non-person involved in research using RAS software (Random Allocation Software) and random blocking will be generated using three and six blocks for assignment in three groups (two intervention groups and a control group). Became Hiding allocation based on the generated sequence will be done using matte envelopes, both closed and shaped, numbered from the number 1 to the end. The first person to enter the study will be enveloped No. 1, and this process will continue until the end . Therefore, the researcher and the person under study will not be informed of the type of allocation (Received Allocation Concealment) until the envelopes are unlocked. In this study, the statistical analyzes and the consequences of the outcome will only be blind. Information about the research objectives and its importance to the company They are given confidential information and their responses. Prior to the beginning of the study, written consent of each participant is taken, Blinding description: Hiding allocation based on
Sequence generated using opaque and envelope envelopes
The shape numbered from the number 1 to the end will be done.
The first person to be included in the study is envelope # 1 data
And this process will continue until the end. So
The researcher and the person under study were allotted
Concealment) will not be known until the envelopes are opened
Had In this analytical and statistical analytic study
The consequences will only be blinding.</study_design>
      <phase>2</phase>
      <hc_freetext>Chronic ischemic heart disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Implementation of four phase early movement protocol for Intervention group 1: Intervention will be performed in two days the first day 24 hours after surgery and after endotracheal tube removal and the second day 48 hours after surgery. The four-phase protocol of moving in bed, sitting in a chair next to the bed, walking in sections and stepping on a pedestal for the first group were compared and the results were compared using the scales listed in the tool section and compared with the other groups. Intervention 2: Intervention group 2: Implementation of three-phase early motion protocol for intervention group 2: Intervention in two days, the first day 24 hours after surgery and after endotracheal tube removal and the second day 48 hours after surgery. The three-phase protocol protocol will focus on the second intervention group, with more focus on pulmonary exercises (including the necessary steps to clear the lungs) (in the methodology section), walking the ward and taking steps on a pedestal. And the groups will be compared. Intervention 3: Control group: Perform routine procedures for the control group: The control group will receive routine actions that involve lowering the bed and walking in the ward 24 hours after surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Requested data will be provided to researchers for statistical analysis of the submitted proposal (meta-analysis).

When:
starting access immediately after publication

To whom:
Data will be available to researchers as well as to journals.

Conditions:
The data will be available to researchers upon request and submission of a proposal to perform meta-analysis using IPD data after being unidentified. Also, in exceptional cases, data will be made available to journals for checking.

Where to obtain:
Refer to the email address (allahbakhshiana@tbzmed.ac.ir).

How to obtain:
The requests will be sent by email and data will be available within a week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Atefeh Allahbakhshian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz School of Nursing and Midwifery, Southern Shariati St., Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>6770 3479 41 +98</telephone>
        <email>allahbakhshiana@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Atefeh Allahbakhshian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz School of Nursing and Midwifery, Southern Shariati St., Tabriz</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5138947977</zip>
        <telephone>6770 3479 41 +98</telephone>
        <email>allahbakhshiana@tbzmedn.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:                                                       1. Selecting units from both ages 18 to 65 years
2. Having a BMI between 20 and 30 mg / m2
3. Stable hemodynamic status without taking inotropic drugs
4. Lack of arrhythmias and angina
5. No Significance of Respiratory Distress and RR under 20 without Symptoms of Systemic Infection.
6.Lack of Motor and Neurological Problems
7.Static pressure above 90 mmHg
8. Time of pump pulmonary than 90 minutes
9. As an expert in cardiac surgery
10. Having no previous history of pulmonary disease
11. A psychological and mental illness that will be examined by examining a patient's case and completing a mental-mental mental test questionnaire (MMSE) before entering the study. If the MMSE score of the patient in the heart surgery department and before entering the intensive care unit in the range of 30 -25 were enrolled in the study and will be excluded from the study if they have dementia and pathologic features.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Exclusion criteria:                                                       1. Cardiovascular and respiratory tract during and after admission in the ICU
2. Time for mechanical ventilation over 24 hours
3. Heart rate above 120 or uncontrolled arrhythmias
4. Unstable angina
5. Open sternum
6. Oxygen substitution under 90
7. Taccharide and bradycardia
8. EF below 40
9. No ability to communicate after entering the intensive care unit
10. The chest tube thickness is more than 100 cc at four hours
11. The time of the heart-pulmonary pump is 90 minutes.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I25.82</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>chronic total occlusion of coronary artery</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Implementation of four phase early movement protocol for Intervention group 1: Intervention will be performed in two days the first day 24 hours after surgery and after endotracheal tube removal and the second day 48 hours after surgery. The four-phase protocol of moving in bed, sitting in a chair next to the bed, walking in sections and stepping on a pedestal for the first group were compared and the results were compared using the scales listed in the tool section and compared with the other groups.</i_keyword>
      <i_keyword>Intervention group 2: Implementation of three-phase early motion protocol for intervention group 2: Intervention in two days, the first day 24 hours after surgery and after endotracheal tube removal and the second day 48 hours after surgery. The three-phase protocol protocol will focus on the second intervention group, with more focus on pulmonary exercises (including the necessary steps to clear the lungs) (in the methodology section), walking the ward and taking steps on a pedestal. And the groups will be compared</i_keyword>
      <i_keyword>Control group: Perform routine procedures for the control group: The control group will receive routine actions that involve lowering the bed and walking in the ward 24 hours after surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Arterial oxygen saturation. Timepoint: Before the intervention, immediately after the intervention, 15 after intervention. Method of measurement: Using pulse oximetry and assessing arterial blood gases(ABG).</prim_outcome>
      <prim_outcome>Pain. Timepoint: Before the intervention, immediately after the intervention, 15 after intervention. Method of measurement: Analog visual analogue tool: VAS (Visual Analogue Scale).</prim_outcome>
      <prim_outcome>Levels of cognitive status. Timepoint: Before the study, after reading and end intervention. Method of measurement: Short Psycho-Mental Testing Tool: MMSE (Mini-Mental State Examination).</prim_outcome>
      <prim_outcome>Frequency of pulmonary complications. Timepoint: Before the intervention, on the last day of intervention. Method of measurement: Using CXR and Physician Visit.</prim_outcome>
      <prim_outcome>Arterial blood gas. Timepoint: before intervention and after 15 minute after end intervention. Method of measurement: ABG.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Duration of stay in hospital and ICU. Timepoint: On the day of the patient's discharge from ICU and Hospital. Method of measurement: The patient's stay in the hospital and ICU will be determined by calculating the days of admission.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-09-11</approval_date>
        <contact_name>Ethics committe of Tabriz university of medical sciences</contact_name>
        <contact_address>Tabriz University of Medical Sciences, Golgasht ave. Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
